Honasa Buys 58% of Fluence Pharma for ₹135 Cr, Launches Honasa Health for Nutraceuticals
Mamaearth parent Honasa Consumer is acquiring 58% of dermatologist-led nutraceuticals firm Fluence Pharma at a ₹135 crore enterprise value, with the remaining 42% to follow over 5-7 years. The board also cleared a wholly owned subsidiary, Honasa Health, to push B2C nutraceuticals across Hair Fact, Skin Fact and Pro Fact brands.
Honasa Consumer, parent of Mamaearth, will acquire 58% of nutraceuticals firm Fluence Pharma for ₹135 crore, with remaining 42% over 5-7 years. It also approved a wholly owned subsidiary Honasa Health for B2C nutraceuticals.